ATA142793A - N-(phenylethyl-beta-ol)aminderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

N-(phenylethyl-beta-ol)aminderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATA142793A
ATA142793A AT0142793A AT142793A ATA142793A AT A142793 A ATA142793 A AT A142793A AT 0142793 A AT0142793 A AT 0142793A AT 142793 A AT142793 A AT 142793A AT A142793 A ATA142793 A AT A142793A
Authority
AT
Austria
Prior art keywords
phenylethyl
beta
production
pharmaceutical compositions
same
Prior art date
Application number
AT0142793A
Other languages
English (en)
Other versions
AT403693B (de
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ATA142793A publication Critical patent/ATA142793A/de
Application granted granted Critical
Publication of AT403693B publication Critical patent/AT403693B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0142793A 1992-07-17 1993-07-19 N-(phenylethyl-beta-ol)aminderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen AT403693B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (2)

Publication Number Publication Date
ATA142793A true ATA142793A (de) 1997-09-15
AT403693B AT403693B (de) 1998-04-27

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0142793A AT403693B (de) 1992-07-17 1993-07-19 N-(phenylethyl-beta-ol)aminderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Country Status (32)

Country Link
US (1) US5447942A (de)
JP (1) JP3204811B2 (de)
AT (1) AT403693B (de)
AU (1) AU672791B2 (de)
BE (1) BE1006429A3 (de)
CA (1) CA2100381C (de)
CH (1) CH687705A5 (de)
DE (1) DE4323976C2 (de)
DK (1) DK84793A (de)
DZ (1) DZ1704A1 (de)
ES (1) ES2067417B1 (de)
FI (1) FI933235A (de)
FR (2) FR2693653B1 (de)
GB (2) GB9215274D0 (de)
GR (1) GR1001565B (de)
HK (1) HK52596A (de)
HU (1) HUT64757A (de)
IE (1) IE73266B1 (de)
IN (1) IN183086B (de)
LU (1) LU88383A1 (de)
MA (1) MA22937A1 (de)
MY (1) MY109395A (de)
NL (1) NL9301241A (de)
NO (1) NO302946B1 (de)
NZ (1) NZ248041A (de)
OA (1) OA09838A (de)
PL (1) PL173783B1 (de)
PT (1) PT101308B (de)
RU (1) RU2060252C1 (de)
SE (1) SE503805C2 (de)
TN (1) TNSN93081A1 (de)
ZA (1) ZA934667B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1771435A4 (de) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst Modulatoren von neurotransmittern des zentralen nervensystems
WO2020148325A1 (en) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Neutral lxr modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GR850936B (de) * 1984-04-17 1985-11-25 Glaxo Group Ltd
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
JPS6485964A (en) * 1987-03-12 1989-03-30 Glaxo Group Ltd Compound
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
EP0422889A3 (en) * 1989-10-10 1991-08-28 Glaxo Group Limited Phenethanolamine compounds

Also Published As

Publication number Publication date
NL9301241A (nl) 1994-02-16
LU88383A1 (fr) 1994-04-01
PL299693A1 (en) 1994-03-21
FI933235A0 (fi) 1993-07-16
SE9302437D0 (sv) 1993-07-16
RU2060252C1 (ru) 1996-05-20
MY109395A (en) 1997-01-31
ES2067417B1 (es) 1995-11-16
NO932383D0 (no) 1993-06-29
AT403693B (de) 1998-04-27
HU9302057D0 (en) 1993-10-28
DK84793A (da) 1994-01-18
AU4204293A (en) 1994-01-20
CH687705A5 (fr) 1997-01-31
IN183086B (de) 1999-09-04
PT101308A (pt) 1994-05-31
SE503805C2 (sv) 1996-09-09
DE4323976A1 (de) 1994-01-20
GB2268742B (en) 1995-11-08
JP3204811B2 (ja) 2001-09-04
NZ248041A (en) 1994-06-27
GB9215274D0 (en) 1992-09-02
FR2693653A1 (fr) 1994-01-21
GR1001565B (el) 1994-05-31
NO932383L (no) 1994-01-18
SE9302437L (sv) 1994-01-18
MA22937A1 (fr) 1994-04-01
NO302946B1 (no) 1998-05-11
DK84793D0 (da) 1993-07-16
GB2268742A (en) 1994-01-19
BE1006429A3 (fr) 1994-08-23
IE930472A1 (en) 1994-01-26
PL173783B1 (pl) 1998-04-30
JPH06157492A (ja) 1994-06-03
US5447942A (en) 1995-09-05
HK52596A (en) 1996-04-03
TNSN93081A1 (fr) 1994-03-17
FI933235A (fi) 1994-01-18
CA2100381C (en) 2004-09-21
DE4323976C2 (de) 2003-05-28
CA2100381A1 (en) 1994-01-18
HUT64757A (en) 1994-02-28
IE73266B1 (en) 1997-05-21
FR2693723B1 (fr) 1994-10-28
GB9314718D0 (en) 1993-08-25
OA09838A (fr) 1994-08-15
ZA934667B (en) 1994-01-25
PT101308B (pt) 1999-10-29
ES2067417A1 (es) 1995-03-16
FR2693723A1 (fr) 1994-01-21
FR2693653B1 (fr) 1994-10-28
DZ1704A1 (fr) 2002-02-17
AU672791B2 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69622992D1 (de) Substituierte heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
DE69006290T2 (de) N-Substituierte Benzyloxyiminderivate, Verfahren zu deren Herstellung und deren Verwendung.
DE3851986D1 (de) Aminsäure-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE150033T1 (de) N,o-sulfatierte heparosane; verfahren zu deren herstellung und diese enthaltende arzneimittel
ATA293589A (de) Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69231679T2 (de) 2-chinolinonderivate, verfahren zu deren herstellung und diese enthaltende fungizide und insektizide
PT70847A (de) N-substituierte aziridin-2-carbonsaurederivate verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
ATE370951T1 (de) Purinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATA56790A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE194616T1 (de) Substituierte 4-phenyl-thiazole derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen die sie enthalten
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3675714D1 (de) Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69421224D1 (de) Nukleosidderivate und Verfahren zu deren Herstellung
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE69318181T2 (de) Papierblock, streifen und verfahren zu deren herstellung
DE69211134D1 (de) Klebstoffe und verfahren zu deren herstellung
DE3583780D1 (de) 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA86690A (de) 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee